GlassScriptPhysician profile
Richard Robertson
NPI 1346322179
$6,039.81
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,868 · 2020: $246 · 2021: $204 · 2022: $251 · 2023: $341 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,674.65 | 2019 | |
| Vertiflex, INC. | $1,820.16 | 2019 | |
| Medtronic, INC. | $288.94 | 2021-2024 | Intellis Adaptivestim, Sonicision |
| Vertos Medical, INC. | $204.48 | 2019-2024 | Mild Device Kit |
| Medtronic USA, INC. | $195.95 | 2019-2020 | |
| Spr Therapeutics, INC | $122.68 | 2021-2023 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $114.62 | 2019-2021 | |
| Boston Scientific Corporation | $69.39 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.86 | 2020-2022 | |
| Abbvie INC. | $60.18 | 2023 | Ubrelvy |
| Pfizer INC. | $59.93 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $44.10 | 2019-2023 | Ztlido |
| Mml US, INC. | $37.46 | 2023 | Reactiv8 |
| Biohaven Pharmaceutical Holding Company LTD. | $37.28 | 2022 | |
| Abbott Laboratories | $36.93 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $26.38 | 2020 | |
| Pacira Therapeutics, INC. | $23.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.18 | 2019 | |
| Amgen INC. | $21.82 | 2019 | |
| Radius Health, INC. | $16.95 | 2019 | |
| Novo Nordisk INC | $16.87 | 2023 | Wegovy |
| Bioventus LLC | $16.59 | 2022 | |
| Redhill Biopharma INC. | $15.45 | 2020 | |
| Collegium Pharmaceutical, INC. | $13.88 | 2019 | |
| Nevro Corp. | $12.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.95 | 2020 | |
| Horizon Therapeutics Plc | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.